스마트 인슐린 펜 시장 규모, 점유율, 성장 분석 : 유형별, 유저빌리티별, 제품별, 접속 유형별, 적응증별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Smart Insulin Pens Market Size, Share, and Growth Analysis, By Type, By Usability, By Product, By Connectivity Type, By Indication, By End User, By Region - Industry Forecast 2025-2032
스마트 인슐린 펜 시장 규모는 2023년에 45억 달러로 평가되며, 2024년 49억 6,000만 달러에서 2032년에는 108억 7,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 10.3%로 성장할 전망입니다.
스마트 인슐린 펜 시장은 효과적인 당뇨병 관리 솔루션에 대한 수요 증가로 인해 강력한 성장세를 보이고 있습니다. 이 혁신적인 디바이스는 적시에 알림과 경고를 제공함으로써 당뇨병 환자의 인슐린 투여를 강화하고 일관성 있는 투여를 보장합니다. 기존 인슐린 펜과 호환이 가능하여 매력적이고 사용하기 쉽다는 장점이 있습니다. 이 펜은 누락된 투여를 쉽게 모니터링하고 종합적인 당뇨병 프로파일을 유지함으로써 1형 당뇨병과 2형 당뇨병을 관리하는 데 매우 유용합니다. 또한 온도 범위와 유효 기간을 모니터링하여 인슐린의 안전한 취급을 보장합니다. 그러나 COVID-19 팬데믹으로 인해 필요한 당뇨병 서비스에 대한 접근이 제한되어 당뇨병 프로파일이 관리되지 않는 문제가 발생했습니다. 전반적으로 스마트 인슐린 펜은 당뇨병 관리에 편리하고 효율적인 접근 방식을 제공합니다.
목차
서론
조사 방법
- 정보 조달
- 2차와 1차 데이터 방법
- 시장 규모 예측
- 시장의 전제조건과 제한
개요
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 산업 분석
주요 시장 인사이트
- 주요 성공 요인
- 경쟁의 정도
- 주요 투자 기회
- 시장 에코시스템
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
스마트 인슐린 펜 시장 규모 : 유형별 & CAGR(2025-2032)
스마트 인슐린 펜 시장 규모 : 유저빌리티별 & CAGR(2025-2032)
스마트 인슐린 펜 시장 규모 : 제품별 & CAGR(2025-2032)
- 시장 개요
- 스마트 인슐린 펜
- 기존형 펜용 어댑터
스마트 인슐린 펜 시장 규모 : 접속 유형별 & CAGR(2025-2032)
스마트 인슐린 펜 시장 규모 : 적응증별 & CAGR(2025-2032)
스마트 인슐린 펜 시장 규모 : 최종사용자별 & CAGR(2025-2032)
- 시장 개요
- 병원과 진료소
- 외래 수술 센터
- 홈케어 설정
스마트 인슐린 펜 시장 규모 : 지역별 & CAGR(2025-2032)
- 북미
- 유럽
- 독일
- 스페인
- 프랑스
- 영국
- 이탈리아
- 기타 유럽 지역
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 상위 5사의 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 최근 시장 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업의 기업 개요
- 기업의 상세
- 제품 포트폴리오 분석
- 기업의 부문별 점유율 분석
- 매출의 전년대비 비교(2022-2024)
주요 기업 개요
- Novo Nordisk A/S(Denmark)
- Eli Lilly and Company(USA)
- Medtronic plc(Ireland)
- BD(Becton, Dickinson and Company)(USA)
- Ypsomed Holding AG(Switzerland)
- Companion Medical(USA)
- Digital Medics Pty Ltd(Australia)
- Biocorp(France)
- Emperra GmbH(USA)
- E-Health Technologies(Germany)
- Bigfoot Biomedical, Inc.(USA)
- Hoffmann-La Roche AG(Switzerland)
- Tandem Diabetes Care, Inc.(USA)
- Insulet Corporation(USA)
- Abbott Laboratories(USA)
- Terumo Corporation(Japan)
- Owen Mumford Ltd.(UK)
- SOOIL Development Co., Ltd.(South Korea)
- Pendiq GmbH(Germany)
- DarioHealth Corp.(Israel)
결론과 제안
KSA
Smart Insulin Pens Market size was valued at USD 4.5 billion in 2023 and is poised to grow from USD 4.96 billion in 2024 to USD 10.87 billion by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).
The smart insulin pen market is experiencing robust growth driven by the increasing demand for effective diabetes management solutions. These innovative devices enhance insulin administration for diabetic patients by providing timely reminders and alerts, ensuring consistent dosing. Their compatibility with existing insulin pens adds to their appeal and ease of use. By facilitating the monitoring of missed doses and maintaining a comprehensive diabetes profile, these pens are invaluable for managing both type 1 and type 2 diabetes. Additionally, they ensure the safe handling of insulin by monitoring temperature ranges and expiration dates. However, the COVID-19 pandemic posed challenges, restricting access to necessary diabetic services and resulting in unmanaged diabetes profiles. Overall, smart insulin pens offer a convenient and efficient approach to diabetes care.
Top-down and bottom-up approaches were used to estimate and validate the size of the Smart Insulin Pens market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Smart Insulin Pens Market Segments Analysis
Global Smart Insulin Pens Market is segmented by Type, Usability, Product, Connectivity Type, Indication, End User and region. Based on Type, the market is segmented into First Generation Pens and Second Generation Pens. Based on Usability, the market is segmented into Prefilled and Reusable. Based on Product, the market is segmented into Smart Insulin Pen and Adaptors for Conventional Pen. Based on Connectivity Type, the market is segmented into Bluetooth and USB. Based on Indication, the market is segmented into Type 1diabetesand Type 2 Diabetes. Based on End User, the market is segmented into Hospitals and Clinics, Ambulatory Surgical Centers and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Smart Insulin Pens Market
The surge in the diabetic population, driven by modern lifestyles and increased demands on the younger generation, has significantly accelerated the market for insulin products. Among these, smart insulin pens have gained considerable traction in recent years. As individuals grapple with the challenges of managing diabetes amidst hectic schedules, traditional methods of tracking glucose levels and insulin dosing become increasingly cumbersome. Smart technology offers a practical solution to these challenges, enhancing convenience and accuracy. Furthermore, the rising prevalence of needle stick injuries has further amplified the appeal of smart insulin pens, prompting manufacturers to ramp up production to capture growing demand and boost revenues in the upcoming years.
Restraints in the Smart Insulin Pens Market
The elevated price point of smart insulin pens could negatively impact their demand worldwide. In developing regions, particularly in Africa, inadequate healthcare systems and unfavorable reimbursement policies deter patients from pursuing necessary treatments and utilizing advanced devices like smart insulin pens. This financial barrier not only limits access to these innovative tools but also exacerbates existing health disparities, as individuals in these areas struggle to receive proper diabetes management solutions. Consequently, the high costs associated with these devices pose a significant challenge to their widespread adoption, particularly in underserved markets where the need for effective diabetes management is critical.
Market Trends of the Smart Insulin Pens Market
The smart insulin pens market is experiencing significant growth driven by advancements in healthcare technology and a rising global diabetic population. Innovative research and development initiatives are facilitating the creation of more sophisticated devices, enhancing patient engagement and management of diabetes. As market manufacturers introduce cutting-edge products that address the unique needs of insulin users, the landscape is evolving to offer greater convenience and accuracy in diabetes care. Moreover, the increasing adoption of digital health solutions and smart connectivity features in insulin pens are anticipated to present lucrative growth opportunities in the coming years, solidifying the market's trajectory.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
Global Smart Insulin Pens Market Size by Type & CAGR (2025-2032)
- Market Overview
- First Generation Pens
- Second Generation Pens
Global Smart Insulin Pens Market Size by Usability & CAGR (2025-2032)
- Market Overview
- Prefilled
- Reusable
Global Smart Insulin Pens Market Size by Product & CAGR (2025-2032)
- Market Overview
- Smart Insulin Pen
- Adaptors for Conventional Pen
Global Smart Insulin Pens Market Size by Connectivity Type & CAGR (2025-2032)
- Market Overview
- Bluetooth
- USB
Global Smart Insulin Pens Market Size by Indication & CAGR (2025-2032)
- Market Overview
- Type 1 Diabetes
- Type 2 Diabetes
Global Smart Insulin Pens Market Size by End User & CAGR (2025-2032)
- Market Overview
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Home Care Settings
Global Smart Insulin Pens Market Size & CAGR (2025-2032)
- North America (Type, Usability, Product, Connectivity Type, Indication, End User)
- Europe (Type, Usability, Product, Connectivity Type, Indication, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Type, Usability, Product, Connectivity Type, Indication, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Type, Usability, Product, Connectivity Type, Indication, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Type, Usability, Product, Connectivity Type, Indication, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Novo Nordisk A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BD (Becton, Dickinson and Company) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ypsomed Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Companion Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Digital Medics Pty Ltd (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biocorp (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Emperra GmbH (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- E-Health Technologies (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bigfoot Biomedical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tandem Diabetes Care, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Insulet Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Owen Mumford Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SOOIL Development Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pendiq GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DarioHealth Corp. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
